EUVIMEDEUVIMED entdecken
FallberichtOpen Access

When Checkpoint Inhibition Goes Off Target: A Rare Case of Pembrolizumab-Induced Acalculous Cholecystitis

Lan Huynh, Stephanie M Paulson, Walid Shaib

Cureus · 28.05.2026

DOI: 10.7759/cureus.109841 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 28.05.2026. Verfasst von Lan Huynh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine, Wellstar Kennestone Regional Medical Center, Marietta, USA. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

acalculous cholecystitisadrenal insufficiencyimmune checkpoint inhibitorimmune-related adverse eventpembrolizumab

Autor:innen und Institutionen

  • Internal Medicine, Wellstar Kennestone Regional Medical Center, Marietta, USA.
  • School of Medicine, Philadelphia College of Osteopathic Medicine - Georgia, Suwanee, USA.
  • Hematology and Oncology, Northwest Georgia Oncology Centers Wellstar, Marietta, USA.

Zitieren

APA

Huynh, L., Paulson, S. M., & Shaib, W. (2026). When Checkpoint Inhibition Goes Off Target: A Rare Case of Pembrolizumab-Induced Acalculous Cholecystitis. Cureus. https://doi.org/10.7759/cureus.109841

Vancouver

Huynh L, Paulson SM, Shaib W. When Checkpoint Inhibition Goes Off Target: A Rare Case of Pembrolizumab-Induced Acalculous Cholecystitis. Cureus. 2026. doi:10.7759/cureus.109841

BibTeX
@article{Huynh2026,
  author = {Huynh, Lan and Paulson, Stephanie M and Shaib, Walid},
  title = {When Checkpoint Inhibition Goes Off Target: A Rare Case of Pembrolizumab-Induced Acalculous Cholecystitis},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.109841}
}
Kostenlos starten →